Serotnin as a possible biomarker in obstructive sleep apnea

Area of Science:

• Neuroscience
• Pulmonology
• Biochemistry

Background:

• Obstructive sleep apnea (OSA) is a common condition with significant public health implications.
• Polysomnography, the standard diagnostic tool, faces limitations in cost, accessibility, and technical requirements, leading to underdiagnosis.
• There is a critical need for accessible and efficient methods to detect sleep-disordered breathing.

Purpose of the Study:

• To review current evidence on biochemical markers for diagnosing OSA.
• To focus on the role of serotonin (5-HT) in relation to OSA and sleep-disordered breathing.
• To explore the potential of biomarker-driven technology for OSA diagnosis and management.

Main Methods:

• Literature review of studies investigating biochemical markers and sleep-disordered breathing.
• Focus on neurochemicals, particularly serotonin (5-HT), and their influence on upper airway dilator motor neurons.
• Analysis of existing evidence linking OSA and 5-HT levels.

Main Results:

• Several neurochemicals, including serotonin (5-HT), play a role in ventilatory control during sleep.
• Evidence suggests a relationship between OSA and various biomarkers.
• Serotonin (5-HT) is highlighted for its key role in ventilatory stimulation and potential relevance to OSA.

Conclusions:

• Biomarker-driven detection technology holds promise for future OSA diagnosis and monitoring.
• Serotonin (5-HT) may play a significant role in the future diagnosis and treatment of OSA.
• Further research is warranted to validate the use of biomarkers for OSA management.